Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.
Noortje G Rossen, Susana Fuentes, Mirjam J van der Spek...
https://pubmed.ncbi.nlm.nih.gov/25836986/Actively Recruiting
Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2026-07-24
400
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating the clinical and microbiological characteristics of patients attending the Gut Microbiota Clinic at Fondazione Policlinico Gemelli. This study focuses on the important role of gut microbiota in human health, including metabolism, immunity, and protection against pathogens. It aims to bridge the gap between microbiome research and clinical practice by establishing a detailed database of patient profiles and outcomes. The study involves microbiome testing and cytokine profiling using samples such as saliva and blood collected from patients. These tests are part of routine clinical care at the clinic, which serves patients with gastrointestinal and extra-intestinal disorders. The clinic operates with a multidisciplinary team including specialists, dietitians, and psychologists. The study will observe changes in microbiota composition and clinical outcomes following standard treatments. Participants will undergo microbiome and cytokine testing while attending the clinic. Researchers will collect data on clinical status using validated diagnostic tools specific to patients conditions, such as scores for ulcerative colitis, Crohns disease, irritable bowel syndrome, and oncology-related outcomes. The study will monitor changes over 24 months, aiming to better understand microbiota profiles and their relationship to health. Participation involves regular assessments without additional experimental treatments beyond standard care.
CONDITIONS
Outcomes of Outpatients in an Gut Microbiota Clinic
G
Gianluca Ianiro, MD, PhD
S
Serena Porcari, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Noortje G Rossen, Susana Fuentes, Mirjam J van der Spek...
https://pubmed.ncbi.nlm.nih.gov/25836986/Yi Yuan, Xiyang Wang, Shun Huang...
https://pubmed.ncbi.nlm.nih.gov/37786296/Paul Moayyedi, Michael G Surette, Peter T Kim...
https://pubmed.ncbi.nlm.nih.gov/25857665/Alyce M Martin, Emily W Sun, Geraint B Rogers...
https://pubmed.ncbi.nlm.nih.gov/31057420/Helle Krogh Pedersen, Valborg Gudmundsdottir, Henrik Bjørn Nielsen...
https://pubmed.ncbi.nlm.nih.gov/27409811/Victoria Horrocks, Olivia G King, Alexander Y G Yip...
https://pubmed.ncbi.nlm.nih.gov/37540126/Dingbo Lin, Denis M Medeiros
https://pubmed.ncbi.nlm.nih.gov/36965327/Himani Pandey, Dheeraj Jain, Daryl W T Tang...
https://pubmed.ncbi.nlm.nih.gov/37935653/Magdy El-Salhy, Jan Gunnar Hatlebakk, Odd Helge Gilja...
https://pubmed.ncbi.nlm.nih.gov/31852769/Sudarshan Paramsothy, Michael A Kamm, Nadeem O Kaakoush...
https://pubmed.ncbi.nlm.nih.gov/28214091/Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead Sponsor